PU23.03 Being a part of the conversation: capacitating youth to participate in HIV prevention conversations using a digital citizen engagement platform in South AfricaPublication OnlyPolicy and advocacy
PU23.04 Lessons learned from the strategic agenda for key populations: Experiences from BrazilPublication OnlyPolicy and advocacy
OA04.02 High protection against vaginal SHIV infection in macaques by a biodegradable implant releasing tenofovir alafenamideOral Abstract SessionPreclinical studies for HIV prevention
OA18.04 Heterologous prime boost immunisations with improved DNA, MVA and protein HIV-1 subtype C vaccines elicit Tier 2 neutralising antibodies in a Chinese rhesus monkey modelOral Abstract SessionPreclinical studies for HIV prevention
OA20.03 Immune perturbation is more profound in newborn than in infant macaques during acute SHIV infectionOral Abstract SessionPreclinical studies for HIV prevention
PE24.01 Efficacy of a vaginal ring containing the gp120 blocker DS003 in pigtailed macaquesE-posterPreclinical studies for HIV prevention
PE24.02 Transport and permeability properties of dapivirine: understanding potential drug-drug interactionsE-posterPreclinical studies for HIV prevention
PE24.04LB Dose response to tenofovir disoproxil fumarate and tenofovir released via intravaginal ring in the sheep vaginal safety and pharmacokinetics modelE-posterPreclinical studies for HIV prevention
PE24.05LB Induction of neutralization breadth and broadly neutralizing antibody lineage responses in HIV envelope BG505 SOSIP immunized infant macaquesE-posterPreclinical studies for HIV prevention
PU24.01 Birth microbiota in HIV-exposed-uninfected infants cause changes in innate and adaptive immune compartments in a murine modelPublication OnlyPreclinical studies for HIV prevention
seek-warrow-warrow-eseek-e391 - 400 of 444 items